Therapeutic efficacy of naloxone hydrochloride combined with hemoperfusion in toxic acute renal failure via the oxidative stress/Nrf2 pathway.
- DOI
- 10.36721/pjps.2026.39.12.346.1
- Published
- 2026 Dec 1
- Container
- Pakistan journal of pharmaceutical sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.36721/pjps.2026.39.12.346.1,
title = {Therapeutic efficacy of naloxone hydrochloride combined with hemoperfusion in toxic acute renal failure via the oxidative stress/Nrf2 pathway.},
author = {Zhu Y and Sun H and Wang Q and Sheng Y and Li Y and Zhang Q},
year = {2026},
journal = {Pakistan journal of pharmaceutical sciences},
doi = {10.36721/pjps.2026.39.12.346.1},
url = {https://doi.org/10.36721/pjps.2026.39.12.346.1}
}RIS
TY - JOUR TI - Therapeutic efficacy of naloxone hydrochloride combined with hemoperfusion in toxic acute renal failure via the oxidative stress/Nrf2 pathway. AU - Zhu Y AU - Sun H AU - Wang Q AU - Sheng Y AU - Li Y AU - Zhang Q PY - 2026 JO - Pakistan journal of pharmaceutical sciences DO - 10.36721/pjps.2026.39.12.346.1 UR - https://doi.org/10.36721/pjps.2026.39.12.346.1 ER -
APA
Y, Z., H, S., Q, W., Y, S., Y, L., & Q, Z. (2026). Therapeutic efficacy of naloxone hydrochloride combined with hemoperfusion in toxic acute renal failure via the oxidative stress/Nrf2 pathway.. Pakistan journal of pharmaceutical sciences. https://doi.org/10.36721/pjps.2026.39.12.346.1
Source records
- pubmed · retrieved 2026-09-26T08:20:42.523Z